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(PDAC) is often lethal because it is highly invasive and metas-
tasizes rapidly. The actin-bundling protein fascin has been
identiﬁed as a biomarker of invasive and advanced PDAC and
regulates cell migration and invasion in vitro. We investigated
fascin expression and its role in PDAC progression in mice.
METHODS: We used KRasG12D p53R172H Pdx1-Cre (KPC) mice
to investigate the effects of fascin deﬁciency on development of
pancreatic intraepithelial neoplasia (PanIn), PDAC, and metas-
tasis. We measured levels of fascin in PDAC cell lines and 122
human resected PDAC samples, along with normal ductal and
acinar tissues; we associated levels with patient outcomes.
RESULTS: Pancreatic ducts and acini from control mice and
early-stage PanINs from KPC mice were negative for fascin, but
approximately 6% of PanIN3 and 100% of PDAC expressed
fascin. Fascin-deﬁcient KRasG12D p53R172H Pdx1-Cre mice had
longer survival times, delayed onset of PDAC, and a lower PDAC
tumor burdens than KPC mice; loss of fascin did not affect in-
vasion of PDAC into bowel or peritoneum in mice. Levels of slug
and fascin correlated in PDAC cells; slug was found to regulate
transcription of Fascin along with the epithelialmesenchymal
transition. In PDAC cell lines and cells from mice, fascin
concentrated in ﬁlopodia and was required for their assembly
and turnover. Fascin promoted intercalation of ﬁlopodia into
mesothelial cell layers and cell invasion. Nearly all human PDAC
samples expressed fascin, and higher fascin histoscores corre-
lated with poor outcomes, vascular invasion, and time to
recurrence. CONCLUSIONS: The actin-bundling protein fascin is
regulated by slug and involved in late-stage PanIN and PDAC
formation in mice. Fascin appears to promote formation of
ﬁlopodia and invasive activities of PDAC cells. Its levels in
human PDAC correlate with outcomes and time to recurrence,
indicating it might be a marker or therapeutic target for
pancreatic cancer.Abbreviations used in this paper: EMT, epithelial to mesenchymal transi-
tion; FKPC, fascin-deﬁcient KRasG12D p53R172H Pdx1-Cre; KPC, KRasG12D
p53R172H Pdx1-Cre; MC, mesothelial cell; PanIN, pancreatic intraepithelial
neoplasia; PDAC, pancreatic ductal adenocarcinoma; Tf, transcription
factor.Keywords: Pancreas; Tumor Progression; Actin Cytoskeleton;
EMT.
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Pdian survival of 6 months and a 5-year survival rate
of <5%.1 Ninety percent of patients have surgically unre-
sectable disease at diagnosis and the majority of patientswho undergo resection for localized lesions develop recur-
rent or metastatic disease.2 Consequently, the development
of more effective strategies to combat metastasis is of
paramount importance.
Human PDAC arises from pancreatic intraepithelial
neoplasias (PanINs) frequently driven by activating muta-
tions in KRas,3 followed by loss or mutation of tumor sup-
pressors, such as p53. Pdx1-Credriven expression of
KRasG12D and Trp53R172H in murine pancreas mimics the
human disease and importantly the histopathology.4 Disease
progression and sites of metastases also mirror the human
disease, providing a good model for human PDAC.5
Slug is a snail family transcription factor that orches-
trates the epithelial to mesenchymal transition (EMT) dur-
ing developmental programs, including in the mouse
pancreas.6 The snail family transcription factors repress
epithelial-speciﬁc genes and enhance mesenchymal-
associated genes.7 Snail proteins bind to speciﬁc E-box
sequences in promoters or introns and regulate gene
expression.7 In the pancreas, slug (also called snail2) is
expressed in a subset of pancreatic embryonic epithelial
cells6 and is associated with endocrine cells delaminating
from primitive ductal tubules and migrating into the pa-
renchyma. Slug expression is highest in those cells of the
embryonic pancreas that have lowest levels of E-cadherin,
including developing islet cells.6 Snail family transcription
factors have also been implicated in tumor progression and
metastatic dissemination.8 EMT occurs in PDAC and is
thought to be an important process in metastatic spread.9,10
Expression of the actin bundling protein fascin is tightly
regulated during development, with fascin present tran-
siently in many embryonic tissues and later only in selected
adult tissues.11,12 The fascin-deﬁcient mouse develops
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adult epithelia, but is often highly elevated in malignant
tumors (reviewed in Hashimoto et al11 and Machesky
et al12) and its overexpression is associated with poor
prognosis.12 Fascin is enriched in cancer cell ﬁlopodia
(reviewed in Hashimoto et al11) and in invadopodia.14,15
Fascin is also expressed by ﬁbroblasts and dendritic cells
and is associated with stroma.11,12 Fascin has also been
associated with metastatic spread of breast cancer and
tumor self seeding.16 However, the effect of loss or inhibi-
tion of fascin has not been previously tested in a sponta-
neous tumor model to determine whether fascin impacts on
tumor progression, invasion, or metastasis.
Materials and Methods
Genetically Modiﬁed Mice
All experiments were performed according to UK Home
Ofﬁce regulations. Mouse models are described in
Supplementary Material.
Immunoblotting and Quantitative Polymerase
Chain Reaction
Immunoblotting and quantitative polymerase chain reac-
tion were carried out by standard protocols (details in
Supplementary Material; n ¼ 3 independent experiments in
triplicate).
Human Tissue Analysis
The human pancreaticobiliary tissue microarray was
described previously.17,18 (see Supplementary Material). All
statistical analyses were performed using SPSS software,
version 15.0 (SPSS Inc, Chicago, IL). We used Oncomine to
examine fascin and slug expression in Jimeno pancreas,19 Pei
pancreas,20 Badea pancreas,21 and Wagner cell line.22
Cell Culture and Expression of Small
Interfering RNA or Constructs
PDAC cell lines were generated from primary pancreatic
tumors from KRasG12D p53R172H Pdx1-Cre (KPC) or fascin-
deﬁcient KPC (FKPC) mice (see Supplementary Material). All
experiments used cells of <6 passages. Standard methods for
small interfering RNA were described previously.14
Tissue Immunoﬂuorescence
For staining fascin, slug, snail, and twist, cells were ﬁxed
with 20C methanol for 10 minutes. For all other staining,
cells were ﬁxed in 4% formaldehyde as described previously.14
Primary antibodies were detected with Alexa 488, Alexa 594,
and Alexa 647-conjugated secondary antibodies. Samples were
examined using Olympus FV1000 or Nikon A1 inverted laser
scanning confocal microscope.
Immunohistochemistry, Live Cell Imaging,
and Cell Growth Assays
Standard methods were used. See Supplementary Material
for details.In Vivo PDAC Transplantation Studies
For mesenteric and diaphragm seeding experiments, 1 
106 PDAC cells in 100 mL phosphate-buffered saline were
introduced into each nude mouse (CD-1 nude females, 6 weeks
old; Charles River Laboratories, Wilmington, MA) by intraper-
itoneal injection and tumor nodules were quantiﬁed after 2
weeks.Results
Fascin Expression Correlates With Poor
Survival and Time to Recurrence In
Human PDAC
Of 122 primary human resected PDAC, fascin was absent
from normal ductal and acinar tissue, but prominent in
PDAC cytoplasm (Figure 1A). Ninety-ﬁve percent of human
PDAC expressed fascin and a high histoscore signiﬁcantly
correlated with decreased overall survival (Figure 1B), high
tumor grade (Figure 1C; median histoscore 104.4 vs 72.8;
P < .05), and vascular invasion (Figure 1D; median histo-
score 94.5 vs 62.2; P < .04). Fascin levels did not correlate
with lymph node status, tumor stage, perineural invasion,
and lymphatic invasion (data not shown). In a multivariate
Cox proportional-hazards regression analysis, high fascin
expression only reached borderline signiﬁcance as an in-
dependent predictor of poor survival, with a hazard ratio of
0.663 (95% conﬁdence interval: 0.441; P ¼ .05)
(Supplementary Table 1). Importantly, fascin levels strongly
correlated with time to recurrence, indicating potential
importance as a predictor of tumor dissemination
(Figure 1E; P < .0005).
To explore a functional role of fascin, we used a mouse
model of pancreatic cancer (KPC mice) recapitulating both
pre-invasive PanIN (grade 13) and invasive, metastatic
PDAC.4 Wild-type ducts and acini and PanIN12 from
10-week-old KPC mice were negative for fascin (Figure 1F).
Around 6% of PanIN3 and 100% of PDAC (both 10-week
and advanced tumors) (Supplementary Table 2) were fas-
cin positive (Figure 1F) and fascin was expressed in both
well and poorly differentiated areas (data not shown).
Fascin null mice had normal-sized pancreata with no
apparent changes in tissue structure or proliferation
(Supplementary Figure 1). Although fascin is weakly
expressed by a few cells in the islets of Langerhans
(Figure 1F), fascin null mice had normal peripheral blood
levels of several markers indicating normal pancreatic
function (Supplementary Table 3). Development of PanIN in
KrasG12D or KrasG12D and p53R172H expressing pancreata
was not changed by loss of fascin (Supplementary Figure 2).
Loss of fascin also did not affect progression, morphology,
or proliferation of cells in an acute model of pancreatitis
using cerulein injection (Supplementary Figure 3). However,
by 21 days of cerulein treatment, fascin was detected in
stroma and epithelium of PanIN of KC animals
(Supplementary Figure 3). However, loss of fascin did not
affect the numbers of monocytes, lymphocytes, or neutro-
phils recruited to acute PanINs, revealing no gross abnor-
malities in the immune response to PanIN in the fascin null
Figure 1. High fascin histoscore predicts poor survival and recurrence in human PDAC. (A) Representative images of fascin
staining in human PDAC. (B) Kaplan-Meier analysis showing cases with high histoscore have poorer outcomes compared with
low expression (P ¼ .011 by log-rank test). (C) Boxplot of fascin histoscore vs tumor grade. (D) Boxplot of fascin histoscore vs
vascular invasion. (E) Boxplot of fascin histoscore vs time to recur. (F) Representative fascin staining in KPC mice as indicated.
Yellow dashes outline the tumor. Insets show high-magniﬁcation views of ductal cells. Purple arrows: fascin-positive cells in
normal islets. Fascin-positive cells in PanIN3 are indicated by purple arrows. Scale bars ¼ 50 mm for normal and PanINs,
200 mm for early PDAC.
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expression was detected in a minority of PanIN3 and all
PDAC and loss of fascin did not detectably affect pancreas
development or PanIN.Loss of Fascin Enhances Survival and
Decreases Early Tumor Burden
Fascin expression or function has not been studied
before in the context of spontaneous tumor development, sowe crossed the fascin knockout mouse with KPC to make
FKPC (Figure 2A). Pdx1-Cremediated recombination
appeared normal in fascin-deﬁcient mice (Supplementary
Figure 4A), which showed a signiﬁcant increase in survival
(Figure 2B). Fascin was expressed in KPC and absent from
FKPC tumors (Figure 2C). Fascin null mice displayed similar
end-point tumor histology and mass (Figure 2D), with no
signiﬁcant difference in the number of undifferentiated or
sarcomatoid lesions in the cohorts (not shown). KPC and
FKPC tumors showed identical proportions of cell
Figure 2. Fascin is
required for early PDAC
formation. (A) Gene tar-
geting strategy for gener-
ating FKPC mice. (B)
Kaplan-Meier curves. (C)
Top: Western blot ana-
lyses of tumor tissue.
Bottom: Histology of
PDAC H&E (top), immu-
nohistochemistry for fas-
cin (middle) and p53
(bottom). (D) Dot plot of
primary tumor-to-body
weight ratios at sacriﬁce
(mean  SEM). (E) Two-
hour bromodeoxyuridine
(BrdU), Ki67þ, phospho-
histone H3þ (PHH3), and
cleaved caspase 3þ (CC3)
cells in PDACs from KPC
and FKPC mice. n  16
ﬁelds from n  4 mice
(mean  SEM). (F) Left:
Number of PDAC-positive
KPC and FKPC mice at
indicated times. *P < .05
by c2 test. Middle: Primary
pancreas-to-body weight
ratios (mean  SEM). *P <
.05; **P < .01 by Mann
Whitney U test. Right:
Relative tumor size, lower
quartile, median, and up-
per quartile are shown.
*P < .05 by Mann Whitney
U test. Scale bars in (C) ¼
100 mm.
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proliferation and death (Figure 2E and Supplementary
Figure 4B). There was no detectable difference in recruit-
ment of T cells (CD3), B cells (CD45R), macrophages (F4/
80), or neutrophils (NIMP) between KPC and FKPC tumors
(Supplementary Figure 4C and D) or difference in platelet
endothelial cell adhesion molecule staining of vasculariza-
tion (Supplementary Figure 4E and F). Together, these data
suggest that cell proliferation, cell death, and fascin-
deﬁcient microenvironment do not contribute signiﬁcantly
to prolonged survival of FKPC mice.
We next examined mice at earlier time points during
PDAC onset and progression. No differences were found at 6
weeks (Figure 2F), but by 10 weeks, 6 of 9 KPC vs 1 of 9
FKPC mice showed tumors (Figure 2F). By 15 weeks, 9 of 10
KPC vs 3 of 6 FKPC mice showed tumors and FKPC showedsmaller tumors (Figure 2F). Loss of fascin signiﬁcantly de-
lays onset of PDAC and reduces early PDAC tumor burden, a
surprising effect that has not been described previously.Slug Drives Fascin Expression in PDAC
During the development of PDAC, ductal cells undergo
EMT.10 Fascin is principally expressed in neural and
mesenchymal derivatives during mammalian embryonic
development,23,24 suggesting that fascin could be a potential
EMT target. EMT involves 3 families of transcription factors,
the snail, ZEB, and bHLH families.7,25 We generated 10 in-
dependent KPC mouse PDAC cell lines that showed het-
erogeneous expression of E-cadherin, fascin, and EMT
transcription factors (Tfs) (Figure 3A), while normal
Figure 3. Fascin is a target of slug in PDAC. (A) Expression of EMT markers in a representative panel of 10 independent KPC
PDAC cell lines. (B) Spearman correlation analysis of fascin and slug protein expression in mouse PDAC cell lines. Fascin and
slug expression level in PDAC cell lines was plotted as relative expression to 070669 PDAC cell line, with other cell lines
numbered as in (A). (C) Left: Western blot analysis with control, Flag-slug, Flag-snail, and twist expressing 070669 PDAC cells
for proteins as indicated. Bar graphs: Relative protein levels of fascin or quantitative polymerase chain reaction analysis mRNA
in 070669 PDAC cells expressing EMT Tfs as indicated (mean  SEM, n ¼ 3). *P < .05; **P <.01, Student t test. (D) Phase and
immunoﬂuorescence microscopy of 070669 PDAC cells expressing EMT Tfs as indicated. Low E-cadherin and high fascin
expressing cells are indicated by yellow arrows. Scale bars in (D) ¼ 10 mm for immunoﬂuorescence, 50 mm for phase. Glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) loading control in (A) and (C).
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fascin or EMT Tfs (Supplementary Figure 5A and B). Co-
expression of E-cadherin and EMT Tfs indicate that most
of our PDAC cell lines were in an intermediate stage of EMT
(Figure 3A, Supplementary Figure 5C).10 Fascin-deﬁcient
PDAC cells also showed a similar heterogeneous expres-
sion of E-cadherin, fascin, and EMT Tfs (Supplementary
Figure 5D). Slug, zeb1, and zeb2 were expressed in all of
our PDAC cell lines, while twist and snail were expressed in
a subset (Figure 3A). Levels of fascin and slug correlated
most closely (Figure 3A and B). Fascin and slug expressionalso correlated in a dataset of 23 human pancreatic cancer
cell lines22 (Supplementary Figure 5E).
Epithelial-like 070669 PDAC cells expressed a low level
of fascin (Figure 3A), which increased >2-fold on Flag-slug
or snail transfection (Figure 3C). Expressing snail or slug
also suppressed E-cadherin but up-regulated fascin
(Figure 3D and Supplementary 6A). Knockdown of slug
reduced fascin expression (Supplementary Figure 6B), and
stable expression of twist (Figure 3C and D and
Supplementary Figure 6A) or transient knockdown of zeb1,
zeb2, or E-cadherin, did not change fascin levels
May 2014 Fascin Expression and PDAC Progression in Mice 1391(Supplementary Figure 6C). Knockdown of fascin did not
affect slug expression (Supplementary Figure 6C). These
observations were conﬁrmed in 061843 PDAC cells
(Supplementary Figure 6D and E). Slug mediates fascin
expression in PDAC cells. In addition, expression of slug or
snail in human pancreatic cancer cells PANC-1 and human
colon cancer cells HT29 induced fascin expression
(Supplementary Figure 6F), suggesting a general effect of
slug and snail on fascin expression in both mouse and hu-
man cancer cells.
Slug and Fascin Co-express During
PDAC Progression
We next investigated expression of fascin and slug dur-
ing EMT changes in KPC PDAC tumors. Interestingly, fascin
and slug were both absent from ductal and acinar cells in
normal pancreas and PanIN1/2 lesions (Figure 4A). Slug
was expressed in fascin-positive (but not negative) PanIN3
lesions (Figure 4A), indicating a correlation between early
markers of EMT and fascin expression during PDAC pro-
gression. Fascin and slug were present in all PDACs,
regardless of E-cadherin staining or differentiation status
(Figure 4B). In addition, fascin expression signiﬁcantly
correlated with slug expression in 3 independent cohorts ofFigure 4. Slug drives fas-
cin expression in
KRasG12D p53R172H Pdx1-
Cre (KPC)-driven PDAC.
(A) Fluorescent images of
sections from normal
pancreas and PanINs co-
stained for E-cadherin (W,
white), fascin (green), slug
(red), and DNA (40,6-
diamidino-2-phenylindole
[DAPI], blue). Insets show
high-magniﬁcation views
of ductal cells. (B) Well
(top) and poorly differenti-
ated (bottom) PDACs from
KPC mice co-stained for
E-cadherin, fascin, and
slug. Insets higher magni-
ﬁcation. Scale bars in (A)
and (B) ¼ 20 mm.pancreatic cancer patients (Supplementary Figure 7). We
propose that slug-induced EMT is an important regulator of
fascin expression in pancreatic cancer.Fascin Is a Direct Slug Target Gene
Given the induction of fascin by slug and their tight as-
sociation in human and mouse pancreatic cancer, we set out
to determine whether fascin is a direct transcriptional target
of slug. We screened the promoter and ﬁrst intron region of
mouse fascin for slug-binding E-box sequences (CACCTG or
CAGGTG).26 We found a potential E-box sequence CACCTG
located within the ﬁrst intron of the mouse fascin gene
at þ2470 to þ2475 bp (Figure 5A). This consensus E-box
sequence is highly conserved among mammalian fascins
(Figure 5A). We designed 3 sets of primers around the pu-
tative E-box sequence: primer set 1 targets the identiﬁed
E-box, while primer sets 2 and 3 target adjacent regions
(Figure 5A). Slug co-precipitated with the putative fascin
E-box element (Figure 5B). Cotransfection of the þ2345
to þ2600 region of the fascin ﬁrst intron in a luciferase
reporter plasmid with a plasmid expressing slug into
070669 PDAC cells drove a signiﬁcant increase in luciferase
activity (Figure 5C). Mutagenesis of the E-box sequence
eliminated the ability of slug to induce luciferase activityBA
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Figure 5. Fascin is a slug target gene. (A) Schematic showing
the potential E-box element in intron 1 of the fascin gene and
regions targeted by 3 primer pairs (#13, red lines). Primer
pair #1 targets the putative E-box, and primer pair and #2 and
#3 target downstream regions. The number in parentheses
indicates distance downstream of transcription start site. (B)
Chromatin from 070669 PDAC cells expressing Flag-slug
was immunoprecipitated using Flag antibody and polymer-
ase chain reaction was performed on the chromatin Immu-
noprecipitation product using 3 primer pairs. Primers for an
E-cadherin promoter E-box element were used as positive
control (mean  SEM). **P < .01 by Student t test. (C) Top: the
putative E-box on the mouse fascin gene and mutations.
Bottom: Relative luciferase activities of 070669 PDAC cells
transfected as indicated. n ¼ 3 experiments (mean  SEM).
**P < .01; *P < .05 by Student t test.
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tional target of slug.
Fascin Is Required for Local and Distant
Metastasis but Not Invasion
We next explored the hypothesis that fascin was a driver
of invasion and metastasis in PDAC. Invasive PDAC was
present in around half of KPC mice, and this was histolog-
ically similar in FKPC mice (Figure 6A and B). More than
80% of KPC mice, but only 30% of FKPC mice, developed
abdominal distension due to hemorrhagic ascites
(Figure 6C). On average, KPC mice harbored 1.57 mL ascitic
ﬂuid, and FKPC mice showed almost none (Figure 6C).
Metastasis was dramatically reduced in FKPC mice
(Figure 6B and Supplementary Table 4). Around 95% of
KPC mice and only 55% of FKPC mice had local metastasisto intestinal mesentery (Figure 6B, D, and E). Forty-four
percent of KPC mice, but only 13% of FKPC mice, devel-
oped diaphragm metastasis (Figure 6B). Similar to local
metastasis, 52% of KPC mice and only 13% of FKPC mice
showed distant liver metastasis (Figure 6B and F). Both
mesenteric and liver metastases of KPC mice were positive
for fascin and p53 (Figure 6D and F). KPC mice had shorter
survival overall than FKPC with liver metastases
(Figure 6E). We conclude that loss of fascin signiﬁcantly
reduces ascites and metastasis to mesentery, diaphragm,
and liver.Fascin Mediates Peritoneal Metastasis Via
Promotion of Transmesothelial Migration
To further investigate the mechanism by which fascin
promotes metastasis, we ﬁrst examined the actin dynamics
of PDAC cells (105768) from the FKPC mice compared with
the same cell line rescued with GFP-fascin. GFP-fascin
concentrated in ﬁlopodia (Figure 7A and Video 1). Fascin
rescue cells showed dynamic ﬁlopodia assembly and turn-
over (Supplementary Figure 8A and B). Filopodia were
signiﬁcantly less frequent, shorter, and shorter-lived in
fascin-deﬁcient cells than fascin-rescued cells
(Supplementary Figure 8B). Lamellipodial dynamics were
greater in fascin-rescued cells (Supplementary Figure 8C
and Video 2). Expression of fascin signiﬁcantly enhanced
protrusion frequency, distance protruded, and protrusion
rate, and decreased protrusion persistence (Supplementary
Figure 8C). Fascin-rescued PDAC cells migrated faster than
fascin-deﬁcient cells (Supplementary Figure 8D and Video 3).
Fascin-expression status did not affect growth in 2D or 3D
(Supplementary Figure 8E), similar to PDAC in vivo. In
addition, fascin-rescued cells behaved similarly to fascin-
deﬁcient cells during anoikis (Supplementary Figure 8E).
Fascin expression increases PDAC cell migration via lamel-
lipodial and ﬁlopodial dynamics, but does not affect growth
and survival.
Formation of mesenteric and diaphragm metastases in-
volves transmigration of cancer cells through the mesothe-
lial cell (MC) layer.27,28 We tested a potential role for fascin
in mesothelial transmigration by plating PDAC cells
(105768) on top of a monolayer of human Met5a MCs. PDAC
cells opened MC junctions and intercalated themselves be-
tween MCs (Supplementary Figure 9A). GFP-fascin localized
intensively to the ﬁlopodia at the leading edge of trans-
migrating PDAC cells (Figure 7A and Video 4). About 75% of
fascin-rescued PDAC cells, but only 35% of fascin-deﬁcient
cells, intercalated by 10 hours (Figure 7B, Supplementary
Figure 9B, and Video 5). Fascin knockdown in KPC
070669 PDAC cells also signiﬁcantly reduced intercalation
(Supplementary Figure 9C–E). GFP-fascinrescued cells
generated protrusions that more effectively transmigrated
than fascin nulls (Figure 7C and Video 6). Nude mice
injected with fascin-deﬁcient PDAC cells developed signiﬁ-
cantly fewer mesenteric or diaphragm metastatic foci than
those with fascin-rescued cells (Figure 7E and F). These
results are consistent with our spontaneous mouse model
and suggest that targeting the interaction of PDAC cells with
Figure 6. Fascin is
required for efﬁcient
metastasis in KPC mice.
(A) H&E staining of (left)
bowel and (right) perito-
neal invasion by cells from
KPC and FKPC tumors.
Insets show zoom of inva-
sion area. Black arrows
indicate direction of inva-
sion. (B) Table shows inci-
dence of invasion (top) and
metastasis (bottom) in
KPC and FKPC mice with
PDAC (*P < .05; **P < .01,
c2 test). (C) Incidence and
volume of ascites in
PDAC-bearing KPC and
FKPC mice (left: **P < .01,
c2 test; right: mean 
SEM. **P < .01 by Mann-
Whitney U test). (D) Top:
Representative pictures of
metastatic nodules (red
arrows) on intestinal mes-
entery of KPC and FKPC
mice. Bottom: Mesenteric
metastasis from KPC mice
H&E (left), fascin (middle),
and p53 (right). (E) Left:
Number of mesenteric
metastases; **P < .01 by
Mann-Whitney U test.
Right: Survival of mice with
liver metastases. Blue and
red dotted lines indicate
median survival for KPC
and FKPC mice, respec-
tively. (F) Liver metastasis
from KPC mice for H&E
(left), fascin (middle), and
p53 (right). Scale bar in (A)
and (D) ¼ 100 mm and in
(F) ¼ 50 mm.
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the mesothelium through fascin depletion is sufﬁcient to
reduce metastasis in vivo.Discussion
Fascin Is an EMT Target in Pancreatic Cancer
Nearly all human PDAC expressed fascin, and a higher
fascin histoscore correlated with poor outcomes, vascular
invasion, and time to recurrence. Similar correlations have
been reported for hepatocellular and extrahepatic bile
duct carcinomas.29,30 Fascin expression in smaller cohorts
of human PDAC and PanIN,31,32 and also in pan-
creatobiliary adenocarcinomas33 and pancreatic intra-
ductal papillary mucinous carcinoma,34 correlated withshorter survival times and more advanced stages. Fascin
expression contributes to progression of human PDAC, but
is only of borderline signiﬁcance as a prognostic indicator,
indicating that other factors contribute to recurrence and
spread.
Fascin is a wnt target in colorectal cancer, where it
localizes to tumor invasive fronts but is down-regulated in
metastases.35 However, in KrasG12D- and p53R172H-driven
pancreatic cancer, fascin is evenly expressed in tumors and
remains highly expressed in liver and peritoneal metas-
tases. Unlike colorectal cancer, the role of wnt signaling in
pancreatic cancer progression is less clear,36 and we ﬁnd
that fascin is an EMT target of the Tf slug. Slug is expressed
in pancreatic endocrine progenitor cells and effects
EMT changes and migration during early embryonic
Figure 7. Fascin mediates
peritoneal metastasis via
promotion of trans-
mesothelial intercalation.
(A) Still image of live GFP-
fascin in PDAC cells
transmigrating through a
red CMTPX CellTracker
(CT)-labeled conﬂuent
Met5A monolayer. Yellow
stars indicate fascin-
positive ﬁlopodia. (B)
Intercalation for individual
cells during 10 hours (n ¼
100 cells, 8 ﬁelds, mean 
SEM, n ¼ 3) **P < .01 by
Student t test. (C) Time-
lapse video stills of PDAC
cells intercalating between
MCs. Protrusions are indi-
cated by yellow arrows. (D)
PDAC cells as indicated
were injected intraperito-
neally into nude mice.
Yellow arrows indicate tu-
mor nodules. (E) Mesen-
teric tumor nodules from
GFP-fascinrescued cells
express fascin and p53.
Insets show high magniﬁ-
cation. (F) Number of
mesenteric and diaphragm
metastases. n ¼ 10 mice
per condition. *P < .05;
**P < .01 by Mann-Whitney
U test. Scale bars in (A),
(C), and (D) ¼ 10 mm and in
(E) ¼ 100 mm.
1394 Li et al Gastroenterology Vol. 146, No. 5
BASIC
AND
TRANSLATIONAL
PANCREASdevelopment.6 We speculate that PDAC cells might reac-
quire slug and fascin during a partial reversion to an
embryonic migratory state.Fascin Contributes to PDAC Progression
There is controversy about whether gene changes that
confer metastatic dissemination of pancreatic cancer (or
other cancers) occur early in tumor formation or later.
A recent study provided compelling evidence based on
lineage tracing of cells by tumor mutation analysis that
metastasis could occur even before there was a recognizable
tumor.10 Our ﬁnding that fascin expression happens during
late PanIN to PDAC transition suggest that EMT changes that
promote metastasis start to happen early. EMT has been
correlated with tumor-initiating (stem) cell properties and
as a part of an EMT program.37 Fascin expression might
allow tumor stem cells to thrive during initial tumor for-
mation, as well as later during metastasis. Perhaps primary
tumors and metastases ﬁrst arise from small nests of fascin-
positive cells in PanIN3. In this case, expression of fascin inPanINs might be predictive of tumor formation and
metastasis.
Fascin in Invasion and Metastatic
Colonization
Fascin is not only expressed in PDAC tumor cells, but
also in stroma of PDAC and of some PanIN. Because our
fascin knockout is global and constitutive, loss of fascin in
the stroma might have contributed to the phenotypes we
observed. However, we could not detect any gross changes
in the stromal immune cell component or blood vessel
density of fascin knockout tumors, and we recently reported
that fascin loss is dispensable for growth of transplanted
tumors.38
Fascin has been implicated in migration and invasion
in vitro, so it was surprising that fascin loss had no effect on
invasion in vivo. We previously observed that only mela-
noma cell lines displaying elongated mesenchymal mecha-
nisms of invasion were dependent on fascin.14 Collective
invasion into bowel or peritoneal wall is not limited by loss
May 2014 Fascin Expression and PDAC Progression in Mice 1395of fascin and might also not be limited by matrix remodeling
or invadopodia formation. Collective PDAC invasion could
occur in physiological clefts between tightly packed collagen
bundles or muscle strands,39 and fascin-mediated pro-
trusions might not be crucial.
We show that fascin null cells are less able to colonize the
mesentery. Rho-associated colied-coil-containing protein ki-
nase and myosin-mediated contractility are required for
transmesothelial migration of human multiple myeloma and
ovarian cancer cells.40,41 We provide mechanistic evidence
that fascin drives long ﬁlopodia that cross between the
mesothelial cells andmake initial contactwith the substratum
to aid transmigration. Our study suggests that, at least for
PDAC, it is not invasion of the primary tumor, but rather
colonization of the newsite that ismost affected by fascin loss.Supplementary Material
Note: To access the supplementary material accompanying
this article, visit the online version of Gastroenterology at
www.gastrojournal.org, and at http://dx.doi.org/10.1053/
j.gastro.2014.01.046.ReferencesBA
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Supplementary Methods
Antibodies and Inhibitors
Goat anti-Zeb2 (L-20), rabbit anti-Zeb1(H-102) (Santa
Cruz, Santa Cruz Biotechnology, Santa Cruz, CA); rabbit
antiT-plastin (ab137585), rabbit Ck19 for Western blots
(ab15463) rabbit anti-Pdx1 (ab47267), mouse anti-twist
(ab50887), rat anti-neutrophil antibody (NIMP-R14)
(ab2557), rat anti-CD45R (RA3-6B2) (ab64100), rabbit anti-
pecam (CD31) (ab28364), rabbit anti-myeloperoxidase
(ab9535) and rat anti-F4/80 (CI:A3-1) (ab6640) (Abcam,
Cambridge, MA); rabbit anti-Ki67 (SP6) (Neomarkers, Fre-
mont, CA); mouse antib-catenin, mouse antiE-cadherin
for Western blots and mouse anti-bromodeoxyuridine
(BrdU) (BD Bioscience, San Jose, CA); rabbit phospho-
histone H3 (Ser10) (#9701), rabbit anti-cleaved caspase-3
(Asp175) (#9664), rabbit anti-slug for Western blots
(C19G7) (#9585), rabbit anti-snail (C15D3) (#3879) and
rabbit antiglyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (14C10) (#2118) (Cell Signaling, Danvers, MA); rat
anti-E-cadherin for IF (clone DECMA-1), mouse antia-
actinin (clone BM-75.2) and rabbit anti-amylase (A8273)
(Sigma, St Louis, MO); mouse anti-fascin1 and mouse anti-
S100A4 (Dako, Carpinteria, CA); rabbit anti-p53 (CM-5)
and rabbit anti-CD3 (VP-RM01) (Vector Laboratories, Bur-
lingame, CA); rat anti-Ck19 for immunohistochemistry and
immunoﬂuorescence (TROMA III, Developmental Studies
Hybridoma Bank, Iowa City, IA). Rabbit anti-slug1 for
immunoﬂuorescence was a kind gift from Joel Habener.
Monoclonal biotinylated goat anti-rabbit or mouse IgG sec-
ondary antibody was obtained from (Dako). Alexa594
phalloidin, anti-mouse IgG, anti-rabbit IgG, and anti-rat IgG
AlexaFluor secondary antibodies were obtained from Invi-
trogen (Carlsbad, CA). Horseradish peroxidaseconjugated
secondary antibodies were obtained from Jackson Immu-
noResearch Laboratories (West Grove, PA).
Immunoblotting and Quantitative Polymerase
Chain Reaction
For Western blot analysis, cells or tissue were lysed in
RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40,
0.25% Na-deoxycholate and 0.1% sodium dodecyl sulfate)
with Halt protease inhibitor cocktail (Pierce, Rockford, IL)
and Halt phosphatase inhibitor cocktail (Pierce) for 10 mi-
nutes on ice. Tissue samples were then homogenized with
electronic homogenizer (Precellys 24; Stretton Scientiﬁc Ltd,
Derbyshire, UK) and lysates were separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis and
transferred to polyvinylidene diﬂuoride membranes. West-
ern blotting was performed with the ECL chem-
iluminescence detection kits (Pierce) with appropriate
species-speciﬁc horseradish peroxidaseconjugated sec-
ondary antibodies. The images were recorded and pro-
cessed using GeneSnap software and Bio-Imaging System
(Syngene, Cambridge, UK). Western blots are representative
of typical results obtained on multiple (>3) occasions for
each experiment shown. Quantiﬁcation of Western blots for
small interfering (si) RNA or overexpression experiments
was done using ImageJ to outline the bands on the blots and
calculate the pixel density, the pixel density was then
divided by pixel density for loading control and then results
were compared with the nontargeted control. For quanti-
tative polymerase chain reaction (PCR), total RNA was
extracted from cells with the RNAeasy kit (Qiagen, Valencia,
CA) and complementary DNA and quantitative PCR was
done with DyNAmo SYBR Green 2-Step qRT-PCR Kit
(Thermo Scientiﬁc, Logan, UT) according to manfacturer’s
instruction using speciﬁc oligos for mouse fascin
(QT00165907) (Qiagen). The mRNA levels of the targets
were normalized using primers for GAPDH (QT01658692)
(Qiagen) as a housekeeping gene. Analysis was completed
with Opticon 3 software (Bio-Rad, Herts, UK). Three inde-
pendent experiments in triplicate for each sample were
carried out.
Tissue Microarray Analysis
The human pancreaticobiliary tissue microarray was
described previously.2,3 Brieﬂy, a tissue microarray was
created within the West of Scotland Pancreatic Unit, Uni-
versity Department of Surgery, Glasgow Royal Inﬁrmary.
All patients gave written, informed consent for the collec-
tion of tissue samples, and the local Research Ethics
Committee approved collection. All cases had undergone a
standardized pancreaticoduodenectomy. A total of 1500
cores from a total of 224 cases with pancreaticobiliary
cancer (including 114 pancreatic ductal adenocarcinomas)
with a full spectrum of clinical and pathologic features
were arrayed in slides. At least 6 tissue cores (0.6-mm
diameter) from tumor and 2 from adjacent normal tissue
were sampled. Complete follow-up data were available for
all cases within the tissue microarray analysis. Fascin
expression levels were scored based on staining intensity
and area of tumor cells using a weighted histoscore
calculated from the sum of (1  % weak staining) þ (2 
% moderate staining) þ (3 % strong staining), providing
a semi-quantitative classiﬁcation of staining intensity. The
cutoff for high and low expression of fascin was a histo-
score of 72.8. Kaplan-Meier survival analysis was used to
analyze the overall survival from the time of surgery. Pa-
tients alive at the time of follow-up point were censored.
To compare length of survival between curves, a log-rank
test was performed. All statistical analyses were per-
formed using SPSS software, version 15.0 (SPSS Inc., Chi-
cago, IL).
Cell Culture
PDAC cell lines were generated from primary pancre-
atic tumors taken from fascin/ or fascinþ/þ KRasG12D
Trp53R172H/þ Pdx1-Cre mice and then passaged in growth
media (Dulbecco’s modiﬁed Eagle medium containing
10% fetal bovine serum and 2 mM L-glutamine), PDAC
origin for these cell lines are conﬁrmed with antibody
against Pdx-1 and p53 using Western blots. Primary
PDECs were isolated from control animals and then
cultured and passaged on collagen-coated plates in fully
supplemented medium, as described previously.4 Brieﬂy,
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the pancreata of 3- to 4-month-old wild-type mice were
dissected, minced, and digested at 37C in a Hank’s
balanced salt solution (Hank’s balanced salt solution þ 5
mmol/L glucose þ 0.05 mmol/L CaCl2) containing 2 mg/
mL type V collagenase (Sigma) with agitation by a
magnetic stir bar. After 20 minutes, the digested mate-
rial was ﬁltered through a 40-mm cell strainer (BD Fal-
con; BD Biosciences). Fragments trapped on the mesh
were digested further in 0.05% trypsin0.53 mmol/L
EDTA (Life Technologies, Grand Island, NY) for 2 mi-
nutes, and then proteases were inactivated by the
addition of Dulbecco’s modiﬁed Eagle medium/F12
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal
bovine serum. The tissue then was washed 3 times in
Hank’s balanced salt solution wash to remove collage-
nase completely. The ductal fragments were plated on
2.31 mg/mL rat tail collagen type I (BD Biosciences)
precoated plastic dishes for growth in monolayer, PDECs
were cultured for 4 days and then harvested for
immunoblotting or immunoﬂuorescence. MET5A human
pleural mesothelial cells were obtained from American
Type Culture Collection. MET5A Cells were cultured in a
1:1 ratio of Medium 199 (Gibco) and MCDB105 (Sigma)
supplemented with 10% fetal bovine serum (Gibco). All
experiments were done with cells of <6 passages. PANC-
1 human pancreatic carcinoma and HT29 human colon
adenocarcinoma grade II cell lines were cultured in
medium as mentioned here for PDAC cell lines.
Stable Gene Expression, siRNA Treatments,
and GFP-Fascin Constructs
pPGS-hFlag-Snail (plasmid 25695), pPGS-hFlag-Slug
(plasmid 25696), and pBABE-puro-mTwist (plasmid
1783) were obtained from Addgene (Cambridge, MA).
mRFP-Lifeact and GFP-Lifeact were kind gifts from Dr
Roland Wedlich-Soldner, Max Planck Institute, Martinsreid,
Germany. Mouse PDAC cells expressing ﬂag-snail, ﬂag-slug,
twist, or GFP-tagged human fascin were generated by
retroviral infection using the modiﬁed Retro-X retroviral
expression system (Clontech, Mountain View, CA). To
subclone human GFP-fascin into HindIII and ClaI sites of
the pLHCX retroviral expression vector, an HindIII restric-
tion site, followed by Kozak consensus translation initiation
site was introduced to the 50end of the coding sequence of
GFP-fascin,5 by PCR (50- AGA AAG CTT ATG GTG AGC AAG
GGC GAG GAG CTG TTC -30), with a ClaI restriction site
introduced to the 30 end in the same reaction (50-AGA ATC
GAT A CTA GTA CTC CCA GAG CGA GGC GGG GTC-30), GFP-
fascin was used as template. High-titer, replication-in-
competent retroviral particles were produced in Phoenix
Eco packaging cell line (Orbigen, San Diego, CA). Subse-
quent infection of target lines resulted in transfer of the
coding region of interest, along with a selectable marker.
Pooled cell lines stably expressing the construct of interest
were isolated by selection with hygromycin-B (500 mg/mL;
Invitrogen) for GFP-fascin. Control lines were infected with
retroviral particles expressing an empty pLHCX control
vector transcript, and subjected to an identical selection
procedure. For siRNA experiment, nontargeting control was
from Dharmacon; siRNAs against human fascin (siFascin,
target sequence: CAC GGG CAC CCT GGA CGC CAA). siRNA
against mouse fascin, siFascin 1, target sequence:
CTCAGTCAACTCTGAGCCTTA; siFascin 2 target sequence:
CCCCATGATAGTAAGCTTTGAA; sets of four siRNAs target
mouse fascin (GS14086), slug (GS20583), Zeb1 (GS21417),
Zeb2 (GS24136), and E-cadherin (GS12550) were obtained
from Qiagen. For transient knockdown of mouse fascin,
slug, Zeb1, Zeb2, and E-cadherin, 4 siRNAs targeting each
gene were mixed and diluted to 20 mM and used at 100 nM
for transfection. Procedures used to transfect cells with
siRNA were described previously.5
Immunohistochemistry
Formalin-ﬁxed parafﬁn-embedded sections were
deparafﬁnized and rehydrated by passage through Xylene
and a grade alcohol series. For Alcian blue staining, rehy-
drated parafﬁn sections were stained for 30 minutes at
room temperature in a 3% solution of Alcian blue diluted
in acetic acid and counterstained with eosin. For antibody
staining, antigen retrieval was performed by incubation of
sections in microwave-heated citrate buffer (Dako) in a
pressure cooker, except for anti-F4/80 and anti-NIMP, for
which 10-minute proteinase K retrieval (Dako) was used.
Sections were blocked with peroxidase blocking reagent
(Dako) for 5 minutes. Sections were then blocked in 10%
serum for 1 hour and then incubated with primary anti-
body for 2 hours at room temperature. Sections were
incubated with horseradish peroxidaselabeled secondary
antibody (Dako) for 1 hour and staining was visualized
with 3,30-diaminobenzidine tetra hydrochloride (DAB)
substrate chromogen and hematoxylin was used as the
nuclear counterstain. For amylase/Ck19 dual immunohis-
tochemistry, after primary antibody, sections were incu-
bated with anti-rabbit alkaline phosphataselabeled and
anti-rat horseradish peroxidaselabeled secondary anti-
body for 30 minutes, staining was visualized with DAB
substrate chromogen and blue alkaline phosphatase sub-
strate kit (Vector Laboratories) and mounted with Prolong
Gold Antifade reagent (Invitrogen). For immunoﬂuores-
cence on tissue sections, after antigen retrieval, sections
were blocked with 10% donkey serum for 1 hour and
incubated with primary antibody overnight at 4C. Sections
were then washed in phosphate-buffered saline and incu-
bated with ﬂuorescent-conjugated secondary antibodies
for 1 hour and mounted with Prolong Gold Antifade re-
agent (Invitrogen).
Live Cell Imaging
For live imaging of ﬁlopodia, 105768 PDAC cells
expressing control vector or GFP-fascin were transfected
with GFP or RFP-lifeact using Lipofectamine 2000 according
to the manufacturer’s instructions. Cells were then plated on
glass-bottomed dishes precoated with 20 ug collagen I (BD
Bioscience) overnight. Time-lapse images were captured
every 20 seconds for 10 minutes using an Nikon A1 inverted
laser scanning confocal microscope in a 37C chamber with
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5% CO2. For live imaging of lamellipodia dynamics, 300
images were captured at 1-second intervals on Nikon TE
2000 Time-lapse microscope systems with Perfect-Focus
System (20 objective, 1.5). Lamellipodial kymographs
show pixel densities over time (x-axis) on a single pixel-
wide straight line (y-axis) in the direction of lamellipo-
dial protrusion (Image J plug-in multiple kymograph).
Distance extended (D) was measured against lamellipo-
dial persistence (P), deﬁned as the amount of time that
the cell spends persistently extending a lamellipod before
pausing or entering a retraction phase. Rate of protrusion
(R) is shown as a broken line in Supplementary Figure 8B
and represents the distance protruded (D) divided by the
time of protrusion (P). For live imaging of random cell
migration, cells on plastic dish were captured on Nikon
TE 2000 Time-lapse microscope (10 objective) at 10-
minute intervals for 6 hours. Cell speed was measured
with Image J plug-in manual tracking and chemotaxis tool.
Three hundred cells from 3 experiments were tracked.
For live imaging of transmesothelial migration, green
CMFDA or red CMTPX CellTracker (Molecular Probes,
Eugene, OR) labeled PDAC cells (1.5  105) were added
to conﬂuent Met5A monolayer on 35-mm glass-bottomed
dish precoated with 10 mg/mL ﬁbronectin. Cells were
monitored by time-lapse microscopy at 10-minute in-
tervals for up to 15 hours in a humidiﬁed chamber at
37C and 5% CO2 with an inverted microscope (TE2000;
Nikon), with a 20 objective lens and using MetaMorph
software (Molecular Devices). To quantify intercalation, a
cell was considered as intercalated when its shape was
not round, when it was no longer phase-bright, and when
it was clearly part of the MC monolayer. For live imaging
of protrusion dynamics of transmigrating PDAC cells, GFP-
fascinexpressing PDAC cells were added to red CMTPX-
labeled conﬂuent Met5A monolayer for 3 hours. The
leading protrusion from PDAC cells within the junction
between Met5A cells were imaged using a spinning disk
confocal scan head (Yokogawa CSU-10) attached to an
Nikon A1 inverted microscope.
Cell Growth Assay
For 2D growth assay, 2  104 cells were plated in each
well of 6-well plates at day 0, and number of cells were
trypsinized and counted every day from 1 well of 6-well
plates for 4 days using CASY cell counter (Roche Innova-
tis, Bielefeld, Germany). Each point (mean  SEM) is
derived from the mean of hemocytometer count of cells
from 3 replicate dishes from 3 independent experiments.
3D proliferation assay in collagen I was performed using
Culturex 3D culture cell proliferation assay kit (Culturex
instructions), Brieﬂy, 5  103 cells in 100 mL cell culture
medium supplemented with 2% collagen I were cultured
on the top of the gel plug of 1 mg/mL collagen I in cell
culture medium (pH 7) in 96-well plate for 3 or 4 days and
8 mL of cell proliferation reagent were added to each well
and incubated at 37C chamber with 5% CO2 for 2 hours
and the absorbance was read at 450 nm. For the anoikis
assay, 2  105 cells were plated on 6-well ultra-low
attachment plates for 6 and 24 hours. Cells were
collected, washed once with phosphate-buffered saline
and stained with Alexa Fluor 647 conjugate Annexin
V according to the manufacturer’s instructions. After
washing with phosphate-buffered saline, cells were stained
with propidium iodide (1 mg/mL) and RNaseA (250 mg/
mL) for 30 minutes before processing on BD FACS-Calibur
(BD Bioscience).
Blood Analysis—Whole Blood
Counts
Mice were humanely sacriﬁced with a rising concentra-
tion of carbon dioxide and then bled from the hepatic portal
vein into a syringe containing 50 mL acid citrate dextrose.
Blood was then emptied into a blood tube containing EDTA
for blood cell analysis. Blood cell analysis was completed
using Advia 120 (Siemens, Camberley, UK) and by exami-
nation of a blood smear.
Pancreatic Function
Mice were humanely sacriﬁced with a rising concentra-
tion of carbon dioxide and then bled by cardiac puncture.
Blood was then emptied into a tube containing lithium
heparin (LH/0.5) and centrifuged to separate the plasma
into a new tube. Samples were analyzed by the Clinical
Pathology Laboratory at the University of Glasgow School of
Veterinary Medicine.
Cerulein Treatment and BrdU Assay
Acute pancreatitis was induced by intraperitoneal cer-
ulein injections (50 mg/kg; Sigma): 1 injection per hour for
6 injections and repeated 2 days later. Mice were sacriﬁced
at 1, 7, or 21 days after last injection. For BrdU assay, mice
were injected intraperitoneally with 2.5 mg BrdU (BD
Bioscience) for 2 hours before sacriﬁce.
PanIN and Amylase-Positive Area
Quantiﬁcation
Quantitation of amylase positive area was performed
on DAB-stained sections with amylase antibody. Amylase-
positive area/pancreas area was measured manually with
ImageJ using the freehand selection tool. PanINs were
deﬁned according to previously published guidelines for
reporting of these lesions in genetically engineered
mouse models.6 Brieﬂy, to be deﬁned as PanIN, a lesion
must arise in native pancreatic ducts measuring <1 mm
and should not arise on a background of acinar-ductal
metaplasia. PanIN lesions are then graded as PanIN-1, 2
or 3, according to the severity of cytological and archi-
tectural abnormalities, as detailed in the consensus
guidelines published by Hruban et al.7 Quantitation of
number of PanINs was performed on DAB-stained sec-
tions with CK19 antibody. Final quantitation represents
the mean of 20 of 20 ﬁelds of view from 4 mice. PanIN
lesions were independently graded by one of the in-
vestigators (A.L.) and conﬁrmed by a trainee pathology
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resident (H.T.M.) and another investigator with extensive
experience in mouse pancreatic histopathology (J.M.).
Luciferase Reporter Assay
A region of the ﬁrst intron from the mouse fascin gene
(þ2189 to þ2,735) was subcloned into into SacI and XmaI
sites of pGL3-prom vector (Promega, Madison, WI), by PCR,
an SacI restriction site was introduced to the 50 end (50-AGA
GAG CTC ATG CAG AGG GCA AAG CCT TGG GTG GGG CC-30),
and a XmaI restriction site was introduced to the 30 end in
the same reaction (50-AGA CCC GGG ATA GCT ATG CAG GGC
TTC TCT ATT TGC AAC T-30), mouse genomic DNA was used
as template. Mutation to the E-box was generated using
QuikChange II Site Directed Mutagenesis kit (Agilent, Berk-
shire, UK) according to manufacture’s protocol with primer
pairs: forward: GGG TCA GAG TTC CTT CCT GTT TAG CAA
ACA TTG and reverse: CAA TGT TTG CTA AAC AGG AAG GAA
CTC TGA CCC. Luciferase activity was assayed using dual-
luciferase assay kit (Promega). The ﬁreﬂy luciferase activ-
ity was normalized to that of Renilla luciferase to control
transfection efﬁciency between samples.
Chromatin Immunoprecipitation
Quantitative PCR
Chromatin immunoprecipitation from 070669 PDAC cell
line expressing ﬂag-tagged Slug was performed as described
previously8 using 10 mg monoclonal anti-ﬂag M2, clone M2
(Sigma, F1804) per assay. Chromatin immunoprecipitation
enrichment levels were determined by SyBr green PCR. The
sequence for primer pairs: #1: Forward: ACCATGGC
CTCTCTTGTTTC; Reverse: ACATTCCCAAGAGACGTTTACC;
#2: Forward: AGGTGGGTCTCTGAGTTCTT; Reverse: TTT
GAGACAGGGTTTCTCTGC; #3: Forward: CTGGCCTCGAAC
TCAGAAAT; Reverse: GCATGACCACCAGTTCAAGAC; primer
pair for E-box on mouse E-cadherin promoter was used as
positive control9: Forward: GGGTGGAGGAAGTTGAGG;
Reverse: CTCCCACACCAGTGAGC.
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Supplementary Figure 1. Fascin-deﬁcient mice have normal pancreas morphology and normal survival rate. (A) Dot plot of
pancreas-to-body weight ratios in wild-type and fascin-deﬁcient mice at 5 weeks. (B) Histology analysis of H&E-stained
sections from pancreas of 5-week control or fascin-deﬁcient mice. Representative images (C) and quantiﬁcation (D) of BrdUþ
or Ki67þ duct cells (left) and acinar cells (right) in pancreata from 5-week control and fascin-deﬁcient mice measured by
immunohistochemistry. Red arrows indicate BrdU or Ki67-positive nuclei (n ¼ 4 mice per genotype). (E) Mendelian segregation
of pups at weaning (3 weeks). Six litters from crosses between fascin heterozygous males and females in a mixed background
were recorded. (F) Body mass of control and fascin-deﬁcient mice in a mixed background at 8 weeks. At least 5 mice were
measured for each genotype and sex. Scale bars in (B) and (C) ¼ 50 mm. In (D), data are shown as mean  SEM.
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Supplementary Figure 2. Fascin is not required for PanIN formation. (A) Gene targeting strategy for generating fascin/,
KRasG12D Pdx1-Cre (FKC). (B) Quantitation of spontaneous (4 months) PanIN formation in KC and FKC mice. Left: Dot plot of
measurements of pancreas-to-body weight ratios. Middle: Box plot of amylase-positive area (lower quartile, median, and
upper quartile are shown). Right 2 bar graphs: Relative number and percentage of PanINs of grade 13 per histopathologic
section of pancreas. Data are shown as mean  SEM (n ¼ 6 mice per genotype). (C) Panels show tissue sections with
spontaneous PanIN in FKC compared with KC mice; H&E (top), Alcian blue (middle), and dual immunohistochemistry (IHC) for
CK19 (brown) and amylase (blue) (bottom). (D) Images and quantiﬁcation of BrdU incorporation assay measured by IHC in duct
cells (top) and acinar cells (bottom) in 4-month KC and FKC pancreas. Red arrows indicate BrdU-positive nuclei (n ¼ 4 mice
per genotype). (E) Panels show spontaneous PanIN formation in 6-week FKPC or KPC mice, with H&E (top) and dual IHC for
CK19 (brown) and amylase (blue) (bottom). (F) Quantitation of spontaneous (6 weeks) PanIN formation in KPC and FKPC mice.
Left: Box plot of amylase-positive area (lower quartile, median, and upper quartile are shown). Right 2 bar graphs: Number and
percentage of PanINs of grades 13 per histopathologic section of pancreas. Data are shown as mean  SEM (n ¼ 5 mice per
genotype). Scale bars in (C) and (E) ¼ 100 mm and in (D) ¼ 50 mm.
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Supplementary Figure 3. Fascin is not required for acute pancreatitisinduced PanIN formation. (A) Protocol used for
cerulein-induced PanIN formation in KC and FKC mice. (B) Western blot (top) and immunohistochemistry (IHC) analysis
(bottom) of fascin expression in control and KC mice after phosphate-buffered saline or cerulein treatments (1 day, 7 days, and
21 days post cerulein). (C) Left: Panels show cerulein-induced (21 days post cerulein) PanIN formation in FKC compared with
KC mice, shown by H&E (top), Alcian blue (middle) and dual IHC for CK19 (brown) and amylase (blue) (bottom). Right:
Quantitation of cerulein-induced (21 days post cerulein) PanIN formation in KC and FKC mice. Graphs describe the following,
as indicated: dot plot of pancreas-to-body mass ratios (n ¼ 6 for KC, n ¼ 15 for FKC mice); box plot of amylase-positive area
(lower quartile, median, and upper quartile are shown); relative number of PanIN per ﬁeld and percentage of PanINs of grade
13 per histopathologic section of pancreas. Data are shown as mean  SEM (n ¼ 6 mice per genotype). (D) Images and
quantiﬁcation of BrdU incorporation assay measured by IHC in duct cells (top) and acinar cells (bottom) in KC and FKC
pancreas 21 days post cerulein injection. BrdU-positive nuclei are indicated by red arrows (n ¼ 4 mice per genotype).
(E) Quantiﬁcation of neutrophil (anti-myeloperoxidase [MPO]) recruitment to normal and fascin-deﬁcient pancreas 1 day after
cerulein injection. Data are shown as mean  SEM, n ¼ 4 mice per genotype. (F) Dot plots of whole blood counts from 6-week
control and fascin-deﬁcient mice 21 days post cerulein injection. Left: monocytes, middle: lymphocytes, and right: neutrophils
are shown. Data are shown as mean  SEM. Scale bars in (B) and (C) ¼ 100 mm and in (D) and (E) ¼ 50 mm.
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Supplementary Figure 4. Tumor-intrinsic action of fascin. (A) Pancreata from Rosa26-LSL-tdRFP/þ Pdx1-Cre, fascin/
Rosa26-LSL-tdRFP/þ Pdx1-Cre and Pdx1-Cre mice were analyzed using an OV100 in vivo imaging system. Red ﬂuorescent
protein signaling is detected in whole pancreata from Rosa26-LSL-tdRFP/þ Pdx1-Cre and fascin/ Rosa26-LSL-tdRFP/þ
Pdx1-Cre mice, but not in pancreata from mice only expressing Pdx1-Cre. (B) Representative images of immunohistochemical
staining for Ki67, 2-hour BrdU pulse, phospho-histone H3 (PHH3), and cleaved capspase-3 (CC3). Quantiﬁcation is shown in
Figure 2E. Images (C) and quantiﬁcations (D) of inﬁltration of B cells (CD45R), T cells (CD3), macrophages (F4/80), and
neutrophils (NIMP) into tumors. At least 16 medium-powered ﬁelds from 4 KPC and FKPC PDACs were analyzed. Data are
shown as mean  SEM. (E) Immunohistochemical visualization of platelet endothelial cell adhesion molecule (CD31) in tumors
in KPC and FKPC mice. (F) Quantiﬁcation of (D), no signiﬁcant difference in vascularization. Data are shown as mean  SEM
(n ¼ 4 mice from each genotype). Scale bars ¼ 100 mm.
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Supplementary Figure 5. Slug signaling regulates fascin expression in PDAC cells. (A) Western blot analysis of fascin and EMT
markers in primary ductal epithelial cells (PDEC) isolated from the pancreas of a wild-type mouse and a PDAC cell line 118739
harvested from a KPC mouse. Expression of CK-19 in the cell lines conﬁrms their ductal origin and p53 in 118739 cell line
conﬁrms its PDAC origin. Flag-snail was used as positive control for snail antibody. Loading control: glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). (B) Immunoﬂuorescence microscopy analysis of PDEC and 118739 PDAC cells stained for the indi-
cated proteins. (C) Representative images of example of E-cadherinnegative (127445) and E-cadherinpositive (022160) PDAC
cells stained for fascin, E-cadherin, and slug. Co-expression of slug and E-cadherin in 022160 PDAC cells suggest partial EMT.
Inserts show individual channels. (D) Expression of EMT markers in a representative panel of 5 independent FKPC PDAC cell
lines. 083320 PKC PDAC cell line was used as positive control for fascin. (E) Spearman correlation analysis of (left) fascin and slug
and (right) fascin and tubulin gene expression in human pancreatic cancer cell lines using Wagner cell line dataset. As a control,
fascin does not correlate with tubulin expression. Scale bars in (B) and (C) ¼ 10 mm.
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Supplementary Figure 6. Slug is an important regulator of fascin expression. (A) Immunoﬂuorescence microscopy analysis of
070669 PDAC cells transduced with vector (control), Flag-slug, Flag-snail, and twist and stained for the proteins as indicated.
Slug, snail, and twist overexpressing cells are indicated by yellow arrows. (B) Western blots (left) and quantitation (right) of
proteins as indicated with 070669 PDAC cells treated with slug siRNA. Data are shown as mean  SEM. **P < .01 by Student t
test. Loading control: a-actinin. (C) Western blot analysis of proteins as indicated with 070669 PDAC cells treated with Zeb1
(top left), Zeb2 (top right), E-cadherin (bottom left), and fascin (bottom right) siRNA. Loading controls: glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and a-actinin, as indicated. (D) Phase contrast images of 061843 PDAC cells
transduced with vector (control), Flag-slug, Flag-snail, and twist as indicated. (E) Western blot analysis with control, Flag-slug,
Flag-snail, and twist expressing 061843 PDAC cells for proteins as indicated. Loading control: a-actinin. (F) Western blot
analysis with control, Flag-slug, Flag-snail expressing PANC-1 (left) and HT29 (right) human pancreatic and colon cancer cells
for proteins as indicated. Loading control: a-actinin. Scale bars in (A) ¼ 10 mm and in (D) ¼ 50 mm.
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Supplementary Figure 7. Slug correlates with fascin in human pancreatic cancer. Spearman correlation analysis of fascin and
slug (left) or tubulin (right) gene expression in human pancreatic cancer using the Badea dataset (A), Pei dataset (B), and
Jimeno dataset (C). Fascin correlation with tubulin was used as a control.
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Supplementary Figure 8. Fascin regulates lamellipodia dynamics and migration but not cell proliferation. (A) Western blots of
105768 FKPC mouse PDAC cells expressing control vector (pLHCX), human GFP-fascin, and fascin siRNA treated rescue
cells. Loading control: glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (B) Left: Control vector and GFP-fascin
expressing FKPC 105768 cells expressing RFP or GFP-lifeact. Yellow stars indicate ﬁlopodia. Bar graphs show box plots
of quantiﬁcations as indicated. **P < .01 by Student t test. (C) Top: Representative kymograph pictures of GFP-fascin rescued
and fascin-deﬁcient PDAC cells (derived from Video 2). Green lines indicate persistence time for each protrusion, yellow stars
indicate each protrusion. Pixel intensities along a 1-pixel wide line were used to generate the kymograph from the corre-
sponding Video 2; a magniﬁed region (outlined in red) is displayed on the top. Red lines indicate the parameters for one
protrusion. D, protrusion distance; P, protrusion persistence; and R, protrusion rate. Bottom bar graphs: Frequency of
lamellipodial protrusion events, distance, protrusion rate, and persistence of individual lamellipodial protrusions. Values are
the means of means from at least 30 cells. Data are shown as mean  SEM. **P < .01 by Student t test. (D) Left: Migration
speed of 105,768 cells expressing vectors/siRNA, as indicated. More than 300 cells from 3 experiments were randomly
selected and mean migration speed during 6 hours was plotted according to frequency in the population. **P < .01 by t test.
Right: 6-hour tracks of individual cell migration, black tracksmigrated faster than 0.5 um/min, red indicates slower. (E) Top left:
2D proliferation assay, no difference between control vector and GFP-fascin expressing FKPC 105768 cells (n ¼ 3). Top right:
3D collagen I cell proliferation assay, no difference between control vector and GFP-fascin expressing FKPC 105768 cells.
Data are shown as mean  SEM (n ¼ 3). Bottom left: Western blot analysis of the effects on the viability of control vector and
GFP-fascinexpressing FKPC 105768 cells grown in normal culture plates and ultra-low attachment plate for 24 hours to
induce anoikis with cleaved-caspase 3 antibody. Bottom right: Fluorescence-activated cell sorting analysis using Annexin V
and propidium iodide for cells undergoing anoikis with control vector and GFP-fascinexpressing FKPC 105768 cells cultured
in ultra-low attachment plate for 6 and 24 hours, attached cells were used as negative control. Data are shown as mean 
SEM (n ¼ 3).
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Supplementary Figure 9. Fascin regulates transmesothelial migration. (A) Representative image of PDAC cell trans-
mesothelial migration. Met5A cells on a ﬁbronectin-coated glass-bottom dish stained with b-catenin and 40,6-diamidino-2-
phenylindole (top left). Green CMFDA-labeled fascin-expressing PDAC 070669 cells were added to MCs for 2 hours
(attachment, top right), 5 hours (junction open, bottom left), and 10 hours (intercalated, bottom right). Insert shows the junction
opening of Met5A cells by PDAC cells. (B) Green CMFDA-labeled 070669 PDAC cells (green) were added to conﬂuent MCs
(labeled with b-catenin [white] and phalloidin [red]) grown on a ﬁbronectin-coated glass-bottom dish. Cells were ﬁxed after
10 hours and their localization was analyzed by confocal microscopy. Top and bottom views of the MC monolayers are shown.
(C) Western blots analysis of transient fascin knockdown in 070669 PDAC cells. Loading control: glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). (D) Representative image of green CMFDA-labeled nontargeting (NT) or fascin siRNA expressing
070669 PDAC cells added to MCs for 5 hours. Top images show the MC monolayer. Middle and bottom images show the 3D
top and bottom view of the MC monolayers. (E) Quantiﬁcation of intercalation for NT and fascin siRNA-treated 070669 cells
5 hours after seeding on MC monolayers. Data are shown as mean  SEM (n ¼ 3). **P < .01 by t test. Scale bars in (A) and
(D) ¼ 10 mm.
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